Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02061657Phase 3Completed
Phase 3, randomised, double-blind trial in leiomyoma comparing Misoprostol Group with Placebo Group (2 arms). Primary endpoint: Intraoperative blood loss at 1 hour. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02061657.